The Delta variant's spread across the U.S. has created a pandemic of the unvaccinated and, like many aspects of the past year and a half, one that each state is experiencing differently.

In these records, Treasury Secretary Steven Mnuchin exchanged emails with top executives at large corporations, including General Electric and Ford.

New documents reveal how the private prison contractor reacted to the pandemic in its early days last spring

During the first months of the coronavirus pandemic, the federal government's frequent lack of clarity and the absence of a clear leadership structure hampered health agencies' and state officials' response to the crisis. American Oversight is investigating the coordination problems that beset federal and local health departments during the spring of 2020.

As the coronavirus spread through crowded and already dangerous meatpacking plants, companies not only sought to avoid closures but also to reduce important safety regulations. American Oversight has been investigating the meat industry's influence at federal agencies, including the Department of Agriculture, during the Covid-19 pandemic.

For the latest news on the pandemic, as well as updates on various oversight investigations, sign up for our bi-weekly Covid-19 Oversight News email.

Records from the Department of Justice of communications from specific groups working on judicial nominations in response to American Oversight's request for records reflecting communications between attorneys involved in challenges to the Affordable Care Act, and Michael Cannon, Director of Health Policy Studies for the Cato Institute.

For the latest news on the pandemic, as well as updates on various oversight investigations, sign up for our weekly Covid-19 Oversight News email.

FOIA request to the Department of Health and Human Services asking for decision memoranda and email communications related to the alleged seizure, rerouting, or interference with states' and hospitals' orders of coronavirus-response supplies.

FOIA request to the U.S. Securities and Exchange Commission for documents relevant to any agency investigations into Emergent BioSolutions CEO Robert Kramer's sale of his company's stock shortly before its stock prices plummeted because of the contamination of Johnson & Johnson Covid-19 vaccines.